Challenges & Successes in Moving Promising Preclinical Cannabinoid Drug Candidates to the Clinic
Time: 1:30 pm
day: Day One Track A - afternoon
Details:
- Identify robust pre-clinical drug targets for cannabinoid drug development
- Evaluate pre- and post-COVID cannabinoid drug development challenges: spotlight on systemic inflammatory disease
- Examine future development of cannabinoid drug products for expanded disease indications
